A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
Clinical trial NCT05599334 · COMPLETED
Trial details
- NCT number
- NCT05599334
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-05
- Primary completion
- 2023-01-30
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.